AR (Androgen Receptor)
7 drugsPredictive biomarker for patient selection in 7 indications
7
Approved Drugs
7
Indications
7
Companies
AR (Androgen Receptor) is a precision-medicine biomarker linked to 7 FDA-approved targeted drugs from 7 companies, spanning 7 indications including Acne Vulgaris, Metastatic Castration-Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer. Explore the targeted therapies, indications, testing methods, and companies developing AR (Androgen Receptor) drugs below.
Search AR (Androgen Receptor) Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting AR (Androgen Receptor)
AR (Androgen Receptor) Indications
Acne Vulgaris Metastatic Castration-Sensitive Prostate Cancer Non-Metastatic Castration-Resistant Prostate Cancer Metastatic Prostate Cancer Prostate Cancer Castration-Resistant Prostate Cancer Non-Metastatic Castration-Sensitive Prostate Cancer